These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

273 related items for PubMed ID: 11465517

  • 1. Efficacy and safety of mirtazapine in major depressive disorder patients after SSRI treatment failure: an open-label trial.
    Fava M, Dunner DL, Greist JH, Preskorn SH, Trivedi MH, Zajecka J, Cohen M.
    J Clin Psychiatry; 2001 Jun; 62(6):413-20. PubMed ID: 11465517
    [Abstract] [Full Text] [Related]

  • 2. Mirtazapine: efficacy and tolerability in comparison with fluoxetine in patients with moderate to severe major depressive disorder. Mirtazapine-Fluoxetine Study Group.
    Wheatley DP, van Moffaert M, Timmerman L, Kremer CM.
    J Clin Psychiatry; 1998 Jun; 59(6):306-12. PubMed ID: 9671343
    [Abstract] [Full Text] [Related]

  • 3. Mirtazapine compared with paroxetine in major depression.
    Benkert O, Szegedi A, Kohnen R.
    J Clin Psychiatry; 2000 Sep; 61(9):656-63. PubMed ID: 11030486
    [Abstract] [Full Text] [Related]

  • 4. Mirtazapine versus selective serotonin reuptake inhibitors.
    Thompson C.
    J Clin Psychiatry; 1999 Sep; 60 Suppl 17():18-22; discussion 46-8. PubMed ID: 10446737
    [Abstract] [Full Text] [Related]

  • 5. A double-blind, randomized, group-comparative study of the tolerability and efficacy of 6 weeks' treatment with mirtazapine or fluoxetine in depressed Chinese patients.
    Hong CJ, Hu WH, Chen CC, Hsiao CC, Tsai SJ, Ruwe FJ.
    J Clin Psychiatry; 2003 Aug; 64(8):921-6. PubMed ID: 12927007
    [Abstract] [Full Text] [Related]

  • 6. Efficacy and tolerability of mirtazapine versus citalopram: a double-blind, randomized study in patients with major depressive disorder. Nordic Antidepressant Study Group.
    Leinonen E, Skarstein J, Behnke K, Agren H, Helsdingen JT.
    Int Clin Psychopharmacol; 1999 Nov; 14(6):329-37. PubMed ID: 10565799
    [Abstract] [Full Text] [Related]

  • 7. Does mirtazapine have a more rapid onset than SSRIs?
    Quitkin FM, Taylor BP, Kremer C.
    J Clin Psychiatry; 2001 May; 62(5):358-61. PubMed ID: 11411818
    [Abstract] [Full Text] [Related]

  • 8. Early improvement under mirtazapine and paroxetine predicts later stable response and remission with high sensitivity in patients with major depression.
    Szegedi A, Müller MJ, Anghelescu I, Klawe C, Kohnen R, Benkert O.
    J Clin Psychiatry; 2003 Apr; 64(4):413-20. PubMed ID: 12716243
    [Abstract] [Full Text] [Related]

  • 9. Mirtazapine versus venlafaxine in hospitalized severely depressed patients with melancholic features.
    Guelfi JD, Ansseau M, Timmerman L, Kørsgaard S, Mirtazapine-Venlafaxine Study Group.
    J Clin Psychopharmacol; 2001 Aug; 21(4):425-31. PubMed ID: 11476127
    [Abstract] [Full Text] [Related]

  • 10. Remission with mirtazapine and selective serotonin reuptake inhibitors: a meta-analysis of individual patient data from 15 controlled trials of acute phase treatment of major depression.
    Thase ME, Nierenberg AA, Vrijland P, van Oers HJ, Schutte AJ, Simmons JH.
    Int Clin Psychopharmacol; 2010 Jul; 25(4):189-98. PubMed ID: 20531012
    [Abstract] [Full Text] [Related]

  • 11. Response acceleration with mirtazapine augmentation of citalopram in obsessive-compulsive disorder patients without comorbid depression: a pilot study.
    Pallanti S, Quercioli L, Bruscoli M.
    J Clin Psychiatry; 2004 Oct; 65(10):1394-9. PubMed ID: 15491244
    [Abstract] [Full Text] [Related]

  • 12. Mirtazapine substitution in SSRI-induced sexual dysfunction.
    Gelenberg AJ, McGahuey C, Laukes C, Okayli G, Moreno F, Zentner L, Delgado P.
    J Clin Psychiatry; 2000 May; 61(5):356-60. PubMed ID: 10847310
    [Abstract] [Full Text] [Related]

  • 13. Double-blind, randomized comparison of mirtazapine and paroxetine in elderly depressed patients.
    Schatzberg AF, Kremer C, Rodrigues HE, Murphy GM, Mirtazapine vs. Paroxetine Study Group.
    Am J Geriatr Psychiatry; 2002 May; 10(5):541-50. PubMed ID: 12213688
    [Abstract] [Full Text] [Related]

  • 14. [Mirtazapine versus other antidepressive agents for depression].
    Knud Larsen J.
    Ugeskr Laeger; 2012 Nov 12; 174(46):2864-6. PubMed ID: 23153468
    [Abstract] [Full Text] [Related]

  • 15. Antidepressant efficacy in HIV-seropositive outpatients with major depressive disorder: an open trial of nefazodone.
    Elliott AJ, Russo J, Bergam K, Claypoole K, Uldall KK, Roy-Byrne PP.
    J Clin Psychiatry; 1999 Apr 12; 60(4):226-31. PubMed ID: 10221282
    [Abstract] [Full Text] [Related]

  • 16. The use of mirtazapine in a group of 11 patients following poor compliance to selective serotonin reuptake inhibitor treatment due to sexual dysfunction.
    Koutouvidis N, Pratikakis M, Fotiadou A.
    Int Clin Psychopharmacol; 1999 Jul 12; 14(4):253-5. PubMed ID: 10468319
    [Abstract] [Full Text] [Related]

  • 17. Mirtazapine: a review of its use in major depression.
    Holm KJ, Markham A.
    Drugs; 1999 Apr 12; 57(4):607-31. PubMed ID: 10235695
    [Abstract] [Full Text] [Related]

  • 18. A randomized, double-blind, 24-week study comparing the efficacy and tolerability of mirtazapine and paroxetine in depressed patients in primary care.
    Wade A, Crawford GM, Angus M, Wilson R, Hamilton L.
    Int Clin Psychopharmacol; 2003 May 12; 18(3):133-41. PubMed ID: 12702891
    [Abstract] [Full Text] [Related]

  • 19. Comparison of the effects of mirtazapine and fluoxetine in severely depressed patients.
    Versiani M, Moreno R, Ramakers-van Moorsel CJ, Schutte AJ, Comparative Efficacy Antidepressants Study Group.
    CNS Drugs; 2005 May 12; 19(2):137-46. PubMed ID: 15697327
    [Abstract] [Full Text] [Related]

  • 20. An overview of the clinical efficacy of mirtazapine.
    Benkert O, Muller M, Szegedi A.
    Hum Psychopharmacol; 2002 Jun 12; 17 Suppl 1():S23-6. PubMed ID: 12404666
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.